Amortizing exploitable technology

By BC Staff | Jul 31, 1995 | 7:00 AM GMT

Noteworthy

Amortizing exploitable technology

The benefits of exploiting an enabling technology that can be sold more than once are apparent in Alkermes Inc.'s strategy in developing its ProLease peptide drug delivery technology.

ALKS acquired the technology in

Read the full 383 word article

How to gain access

Continue reading with a
two-week free trial.